Stay updated on Avelumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Solid Tumors Clinical Trial page.

Latest updates to the Avelumab in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding lapse notice and older Revision: v3.4.1; no study content or outcomes were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check37 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status with links for updates. The site revision was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.2%

- Check44 days agoChange DetectedAdded a Show glossary option and updated the page to revision v3.4.0 with the 'Last Update Submitted that Met QC Criteria' label. The previous wording and revision v3.3.4 have been removed.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded a Locations section with state-level entries (Arizona, Arkansas, California, District of Columbia, Florida, Georgia, Illinois, Indiana, Maryland, Michigan, Minnesota, Missouri, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Washington) and a Revision: v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference1%

Stay in the know with updates to Avelumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Solid Tumors Clinical Trial page.